Tidalsense Limited

The WHO estimates that over 7% of the Earth's population suffer from two chronic respiratory conditions: asthma and chronic obstructive pulmonary disease (COPD). The incidence is rising worldwide due to global increases in air pollution and tobacco smoking. Existing clinical technologies lack the precision, predictive power and usability to deliver sustai...

no public description

We have developed a sensitive handheld breathing monitoring device, just by breathing normally into the device we are able to monitor how a person's lungs are performing. The device has been designed to be used by the young, fit and well and frail elderly and is providing clinical teams with new and insightful medical information on patients. The devices ...

**Cambridge Respiratory Innovations Limited (CRiL) has been awarded a grant by Innovate UK to develop a proof-of-concept dosage actuator device for a fixed or variable dose inhaler.** The actuator will be triggered by the user's respiratory performance, based on CRiL's innovative N-Tidal technology that determines respiratory function through the analysis...

About 835,000 people in the UK suffer from Chronic Obstructive Pulmonary Disease (COPD), a progressive respiratory condition. People with COPD experience flare-ups, called exacerbations, which are distressing and can cause permanent damage to their lungs. Cambridge Respiratory Innovations Limited (CRiL), of Swavesey, Cambridgeshire, has developed a respir...

"Cambridge Respiratory Innovations Limited (CRiL), of Swavesey, Cambridgeshire, has been awarded a grant by Innovate UK to develop a ""market-ready"" prototype of an innovative new diagnostic device for chronic respiratory conditions. The programme will take eighteen months to complete and addresses a major unmet need for better respiratory diagnosis. Cur...

"There is a substantial market opportunity for a low-cost personal medical device which can be used by a patient to help monitor and manage their respiratory condition. In the UK alone there are over 800,000 people with Chronic Obstructive Pulmonary Disease (COPD), as well as 5.4 million people with asthma. Globally WHO estimates that there are 64 million...

"Innovate UK has awarded a feasibility research grant to Cambridge Respiratory Innovations Limited, of Swavesey, Cambridgeshire. Currently a clinician needs to use a range of medical devices, from peak-flow meters through spirometers and pulse oximeters to scans and x-rays, to diagnose a respiratory condition. The most commonly used devices to diagnose as...

"Cambridge Respiratory Innovations Limited (CRiL), of Swavesey, Cambridgeshire, has been awarded a grant by Innovate UK to complete a feasibility study into an innovative new diagnostic device for chronic respiratory conditions. Currently a clinician needs to use a range of medical devices, from peak-flow meters through spirometers and pulse oximeters to ...

Cambridge Respiratory Innovations Limited (CRiL) has been awarded an Innovate UK grant to complete the development of a respiratory performance index based on analysis of CO2 in normal tidal breathing. The CRiL team have developed a low-cost personal respiratory monitor which measures the CO2 in normal tidal breathing. Their goal is to develop personal re...

Cambridge Respiratory Innovations Limited (CRiL) has been awarded an Innovate UK grant to complete research into tidal breathing monitoring across a wide range of respiratory conditions. The CRiL team have developed a low-cost personal respiratory monitor which measures the CO2 in normal tidal breathing. Their goal is to develop a range of personal respir...

Respiration rate and exhaled carbon dioxide (CO2) concentrations are known to be key measures in the evaluation of patient health trends in both routine healthcare and emergency healthcare. However routine and reliable measurement of respiration rate is notoriously difficult to do. It is prone to false readings, outside influences and is therefore not con...